Zimmer Biomet’s reason was because of “the more complex and lengthier path with the US Food and Drug Administration (FDA) than initially expected,” Bactiguard said in a news release. The companies have been in partnership for orthopedic products since 2022.
The partnership will remain intact for Zimmer Biomet’s trauma product segment, which was signed in 2019.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.